Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...
New Scientist on MSN
mRNA covid vaccines spark immune response that may aid cancer survival
An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...
RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
BERLIN, OCTOBER 19, 2025 ― Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune ...
A vaccine originally designed to protect against Covid-19 has shown unexpected promise in helping the immune system fight ...
CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...
A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback